Fresenius Medical Care AG & Co. KGaA (FMS)
NYSE: FMS · IEX Real-Time Price · USD
20.10
-0.11 (-0.54%)
Apr 26, 2024, 4:00 PM EDT - Market closed
FMS Revenue
In the year 2023, Fresenius Medical Care AG & Co. KGaA had annual revenue of $21.62B with 4.74% growth. Revenue in the quarter ending December 31, 2023 was $5.54B with 4.26% year-over-year growth.
Revenue (ttm)
$21.62B
Revenue Growth
+4.74%
P/S Ratio
0.55
Revenue / Employee
$180,359
Employees
119,845
Market Cap
11.80B USD
Revenue Chart
* The company reports in EUR currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21.62B | 978.94M | 4.74% |
Dec 31, 2022 | 20.64B | 614.96M | 3.07% |
Dec 31, 2021 | 20.02B | -1.76B | -8.07% |
Dec 31, 2020 | 21.78B | 2.14B | 10.91% |
Dec 31, 2019 | 19.64B | 617.18M | 3.25% |
Dec 31, 2018 | 19.02B | -2.32B | -10.88% |
Dec 31, 2017 | 21.34B | 3.90B | 22.38% |
Dec 31, 2016 | 17.44B | 652.24M | 3.89% |
Dec 31, 2015 | 16.79B | -3.71B | -18.10% |
Dec 31, 2014 | 20.50B | -1.00B | -4.66% |
Dec 31, 2013 | 21.50B | 2.02B | 10.37% |
Dec 31, 2012 | 19.48B | 2.07B | 11.87% |
Dec 31, 2011 | 17.41B | 467.96M | 2.76% |
Dec 31, 2010 | 16.94B | -312.31M | -1.81% |
Dec 31, 2009 | 17.26B | 1.43B | 9.05% |
Dec 31, 2008 | 15.82B | 621.99M | 4.09% |
Dec 31, 2007 | 15.20B | 3.24B | 27.05% |
Dec 31, 2006 | 11.97B | 3.40B | 39.76% |
Dec 31, 2005 | 8.56B | -474.60M | -5.25% |
Dec 31, 2004 | 9.04B | 1.59B | 21.32% |
Dec 31, 2003 | 7.45B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
DaVita | 12.14B |
Charles River Laboratories International | 4.13B |
Incyte | 3.70B |
Dr. Reddy's Laboratories | 2.99B |
Bruker | 2.96B |
Royalty Pharma | 2.35B |
Medpace Holdings | 1.96B |
Insulet | 1.70B |
FMS News
- 5 weeks ago - Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care - PRNewsWire
- 5 weeks ago - Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device - PRNewsWire
- 6 weeks ago - Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources - PRNewsWire
- 7 weeks ago - Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador - PRNewsWire
- 2 months ago - Fresenius Medical Care delivers on commitments in a year of fundamental transformation - PRNewsWire
- 2 months ago - Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies - PRNewsWire
- 2 months ago - Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board - PRNewsWire
- 3 months ago - Fresenius Medical Care Executes on Its Strategic Portfolio Optimization Program and Announces Key Transactions - PRNewsWire